Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations

• Published in: Leukemia Vol. 9; no. 9; p. 1432
• Main Authors: Litz, C E, Davies, S, Brunning, R D, Kueck, B, Parkin, J L, Gajl Peczalska, K, Arthur, D C
• Format: Journal Article
• Language: English
• Published: England 01.09.1995
• Subjects: Acute Disease; Adult; B-Lymphocytes - pathology; Blast Crisis - pathology; Child; Child, Preschool; Down Syndrome - complications; Down Syndrome - genetics; Erythrocytes - pathology; Female; Humans; Immunophenotyping; Infant; Infant, Newborn; Karyotyping; Leukemia, Myeloid - genetics; Leukemia, Myeloid - pathology; Male; Megakaryocytes - pathology; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology; T-Lymphocytes - pathology
• ISSN: 0887-6924

Individuals with Down syndrome have an increased incidence of leukemia compared to the general population. In addition, Down syndrome children may acquire a myeloproliferation that resembles acute leukemia that undergoes a spontaneous, durable remission. To clarify the relationship between these two disorders, the morphologic, immunophenotypic and cytogenetic characteristics of 28 patients with Down syndrome and the morphologic manifestations of acute leukemia were examined. Three cytomorphological groups were discerned. The first two groups consisted of five patients with acute lymphoblastic leukemia (group I) and three patients with acute myeloid leukemia (group II). These leukemias resembled those of non-Down individuals. The third and largest group (group III) consisted of 20 cases of acute myeloid leukemia that showed prominent megakaryocytic and/or erythroid differentiation and occurred in children under 6 years of age. The blasts in this group were non-reactive for myeloperoxidase or non-specific esterase and expressed CD7, CD34 and CD36 with variable expression of CD61, CD13 and CD33. Four patients in this group had an acquired trisomy 8. Four group III leukemias underwent a durable, spontaneous remission within 2 months of diagnosis. There were no morphologic differences between those leukemias in this group that progressed and those that remitted; however, all remissions occurred in newborns. It is concluded that Down syndrome children acquire a characteristic acute myeloid leukemia that has prominent megakaryocytic and/or erythroid differentiation and an unusual immunophenotype. This group of leukemias may undergo a durable, spontaneous remission in the newborn period.